AbbVie (NYSE:ABBV) Price Target Raised to $240.00
AbbVie (NYSE:ABBV – Free Report) had its target price upped by Wells Fargo & Company from $210.00 to $240.00 in a report released on Wednesday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. A number of other research analysts also recently weighed in on ABBV. Bank of America increased […]
AbbVie (NYSE:ABBV – Free Report) had its target price upped by Wells Fargo & Company from $210.00 to $240.00 in a report released on Wednesday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. A number of other research analysts also recently weighed in on ABBV. Bank of America increased […]
